Sign In
Buy ENDP
$0.108
+0 (+0%)
At Close: Jan 27, 2023
Endo to Participate at J.P. Morgan 39th Annual Healthcare Conference
05:00pm, Friday, 18'th Dec 2020
DUBLIN, Dec. 18, 2020 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that members of management will present at the J.P. Morgan Healthcare Conference on Tuesday, January 12, 202
Endo to Participate In Upcoming Investor Conferences
05:00pm, Wednesday, 18'th Nov 2020
DUBLIN, Nov. 18, 2020 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that the Company will participate in two investor conferences. Members of management will participate in the
Endo International plc (ENDP) CEO Blaise Coleman on Q3 2020 Results - Earnings Call Transcript
12:29pm, Friday, 06'th Nov 2020
Endo International plc (ENDP) CEO Blaise Coleman on Q3 2020 Results - Earnings Call Transcript
Endo International (ENDP) Q3 Earnings and Revenues Top Estimates
07:40pm, Thursday, 05'th Nov 2020
Endo (ENDP) delivered earnings and revenue surprises of 271.43% and 13.72%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Endo Reports Third-Quarter 2020 Financial Results And Raises Full Year 2020 Financial Guidance
04:49pm, Thursday, 05'th Nov 2020
DUBLIN, Nov. 5, 2020 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today reported financial results for the third-quarter ended September 30, 2020. "Our third-quarter 2020 results reflect grow
Isofol announces licensing agreement for Paladin Labs Inc. to commercialize arfolitixorin in Canada
07:25am, Monday, 02'nd Nov 2020
GOTHENBURG, Sweden, Nov. 2, 2020 /PRNewswire/ -- Isofol Medical AB (publ) ("Isofol"), (Nasdaq First North Premier Growth Market: ISOFOL) is pleased to announce today a definitive license agreement wit
GOTHENBURG, Sweden, Nov. 2, 2020 /PRNewswire/ -- Isofol Medical AB (publ) ("Isofol"), (Nasdaq First North Premier Growth Market: ISOFOL) has today announced a definitive licensing agreement with Endo
Endo International plc Commences Tender Offer for All Outstanding Shares of BioSpecifics Technologies Corp.
07:00am, Monday, 02'nd Nov 2020
DUBLIN, Nov. 2, 2020 /PRNewswire/ -- Endo International plc (Nasdaq: ENDP) ("Endo") today announced that Endo's wholly-owned indirect subsidiary, Beta Acquisition Corp. ("Merger Sub"), has commenced i
Tracking Larry Robbins' Glenview Capital Management Portfolio - Q2 2020 Update
03:50pm, Friday, 04'th Sep 2020
Glenview Capital Management's 13F portfolio value decreased from $3.68B to $3.63B this quarter. The number of positions decreased from 44 to 43.
Tracking John Paulson's Paulson & Company Portfolio - Q2 2020 Update
09:49am, Wednesday, 19'th Aug 2020
John Paulson’s 13F portfolio value increased from $2.62B to $3.13B this quarter. Paulson & Company's largest three positions are Bausch Health, Horizon Therapeutics, and SPDR Gold ETF.
New York, New York--(Newsfile Corp. - August 18, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities o
LOS ANGELES, CA / ACCESSWIRE / August 18, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Endo International plc ("End
SHAREHOLDER ALERT: NSP TUFN ENDP: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
06:15pm, Tuesday, 18'th Aug 2020
NEW YORK, NY / ACCESSWIRE / August 18, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies.
Los Angeles, California--(Newsfile Corp. - August 18, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Endo Internatio
LAWSUITS FILED AGAINST ENDP, GWRE and FE - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS
04:00pm, Tuesday, 18'th Aug 2020
NEW YORK, NY / ACCESSWIRE / August 18, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies w
